NOT-DA-01-023: CLINICAL TRIAL NETWORK PHARMACY AND CLINICAL SUPPORT (CTN PCS)

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®


CLINICAL TRIAL NETWORK PHARMACY AND CLINICAL SUPPORT (CTN PCS)

Release Date:  March 7, 2001

NOTICE:  NOT-DA-01-023

RFP AVAILABLE:  N01DA-1-2200

National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is soliciting proposals from 
qualified businesses to provide resources to support the newly established 
Clinical Trials Network (CTN).  In an effort to dramatically improve drug 
abuse treatment throughout the country, NIDA established the CTN in September 
1999 and has awarded fourteen Regional Research and Training Centers (RRTCs). 
 Each RRTC has contractual agreement with 5-8 Community-based Treatment 
Programs (CTPs).  Multi-site clinical trials will be conducted in these 
community program sites.  This project is to support the work of the CTN in 
its conducting of clinical trials to evaluate the effectiveness of science-
based behavior therapies and/or safe and effective medication therapies.  For 
medication trials, the Contractor shall prepare medication kits for the 
patients, manage a drug testing quality assurance program, and distributing 
clinical supplies. No actual clinical or laboratory studies will be conducted 
under this contract.  It is estimated that a three-year incrementally funded, 
level of effort type contract using work assignments will result from this 
procurement.  The project will include two options, each for an additional 
year. RFP No. N01DA-1-2200 will be available electronically on or about March 
26, 2001, and may be accessed through the NIDA website at the following 
address: (URL:  http://www.nida.nih.gov/RFP/RFPList.html)  Please note that 
the RFP for this acquisition will be streamlined to include only the Work 
Statement, Deliverables and Reporting Requirements, Special Requirements and 
Mandatory Qualifications, Technical Evaluation Criteria, and other necessary 
Proposal Preparation Instructions.  All information required for the 
submission of an offer will be contained in or accessible through the 
electronic RFP package.  Response to the RFP will be due on or about May 10, 
2001.  Any responsible offeror may submit a proposal which will be considered 
by the Government.  This advertisement does not commit the Government to award 
a contract.

Point of Contact:	Kenneth E. Goodling, Contracting Officer
National Institute on Drug Abuse, NIH
Contracts Management Branch, OPRM
6001 Executive Blvd., Room 3105, MSC 9543
Bethesda, Maryland  20892-9543
Electronic Mail Address:  [email protected]
Telephone:  (301) 443-6677
Fax:  (301) 443-7595
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices